These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 23159963

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The safety of magnetic resonance imaging in patients with programmable implanted intrathecal drug delivery systems: a 3-year prospective study.
    De Andres J, Villanueva V, Palmisani S, Cerda-Olmedo G, Lopez-Alarcon MD, Monsalve V, Minguez A, Martinez-Sanjuan V.
    Anesth Analg; 2011 May; 112(5):1124-9. PubMed ID: 21474658
    [Abstract] [Full Text] [Related]

  • 5. Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable SynchroMed pumps.
    Taha J, Favre J, Janszen M, Galarza M, Taha A.
    Neurosurgery; 2004 Aug; 55(2):390-3; discussion 393-4. PubMed ID: 15271246
    [Abstract] [Full Text] [Related]

  • 6. Malfunction of SynchroMed II baclofen pump delivers a near-lethal baclofen overdose.
    Sgouros S, Charalambides C, Matsota P, Tsangaris I, Kostopanagiotou G.
    Pediatr Neurosurg; 2010 Aug; 46(1):62-5. PubMed ID: 20516743
    [Abstract] [Full Text] [Related]

  • 7. Fentanyl overdose caused by malfunction of SynchroMed II intrathecal pump: two case reports.
    Maino P, Koetsier E, Perez RS.
    Reg Anesth Pain Med; 2014 Aug; 39(5):434-7. PubMed ID: 25075457
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
    Lin CP, Lin WY, Lin FS, Lee YS, Jeng CS, Sun WZ.
    J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
    [Abstract] [Full Text] [Related]

  • 10. Treatment of medically refractory cancer pain with a combination of intrathecal neuromodulation and neurosurgical ablation: case series and literature review.
    Bentley JN, Viswanathan A, Rosenberg WS, Patil PG.
    Pain Med; 2014 Sep; 15(9):1488-95. PubMed ID: 24931480
    [Abstract] [Full Text] [Related]

  • 11. Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients.
    Smith TJ, Coyne PJ.
    J Palliat Med; 2005 Aug; 8(4):736-42. PubMed ID: 16128647
    [Abstract] [Full Text] [Related]

  • 12. Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report.
    Mohammed I, Hussain A.
    BMC Clin Pharmacol; 2004 Aug 09; 4():6. PubMed ID: 15301690
    [Abstract] [Full Text] [Related]

  • 13. Implanted intrathecal drug delivery systems and radiation treatment.
    Gebhardt R, Ludwig M, Kirsner S, Kisling K, Kosturakis AK.
    Pain Med; 2013 Mar 09; 14(3):398-402. PubMed ID: 23432925
    [Abstract] [Full Text] [Related]

  • 14. An in vivo canine study to assess granulomatous responses in the MedStream Programmable Infusion System (TM) and the SynchroMed II Infusion System®.
    Michael A, Buffen E, Rauck R, Anderson W, McGirt M, Mendenhall HV.
    Pain Med; 2012 Feb 09; 13(2):175-84. PubMed ID: 22239738
    [Abstract] [Full Text] [Related]

  • 15. Pontine hemorrhage following a recently implanted intrathecal drug delivery system.
    Rosenfeld DM, Trentman T, Patel NP.
    Pain Pract; 2009 Feb 09; 9(4):312-6. PubMed ID: 19500275
    [Abstract] [Full Text] [Related]

  • 16. Intrathecal morphine pump for neuropathic cancer pain: a case report.
    Gogia V, Chaudhary P, Ahmed A, Khurana D, Mishra S, Bhatnagar S.
    Am J Hosp Palliat Care; 2012 Aug 09; 29(5):409-11. PubMed ID: 21868426
    [Abstract] [Full Text] [Related]

  • 17. Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: a pilot series.
    Kongkam P, Wagner DL, Sherman S, Fogel EL, Whittaker SC, Watkins JL, McHenry L, Lehman GA.
    Am J Gastroenterol; 2009 May 09; 104(5):1249-55. PubMed ID: 19367269
    [Abstract] [Full Text] [Related]

  • 18. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain.
    Deer TR, Smith HS, Burton AW, Pope JE, Doleys DM, Levy RM, Staats PS, Wallace MS, Webster LR, Rauck RL, Cousins M, Center For Pain Relief, Inc.
    Pain Physician; 2011 May 09; 14(3):E283-312. PubMed ID: 21587338
    [Abstract] [Full Text] [Related]

  • 19. Massive clonidine overdose during refill of an implanted drug delivery device for intrathecal analgesia: a review of inadvertent soft-tissue injection during implantable drug delivery device refills and its management.
    Johnson ML, Visser EJ, Goucke CR.
    Pain Med; 2011 Jul 09; 12(7):1032-40. PubMed ID: 21672143
    [Abstract] [Full Text] [Related]

  • 20. Safety of active implantable devices during MRI examinations: a finite element analysis of an implantable pump.
    Büchler P, Simon A, Burger J, Ginggen A, Crivelli R, Tardy Y, Luechinger R, Olsen S.
    IEEE Trans Biomed Eng; 2007 Apr 09; 54(4):726-33. PubMed ID: 17405380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.